Commerzbank Aktiengesellschaft’s Insys Therapeutics, Inc. INSY Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-33,589	Closed	-$309K	–	1017
2016 Q4	$309K	Sell	33,589 -3,301	-9%	-$37.3K	﹤0.01%	771
2016 Q3	$435K	Buy	36,890 +4,949	+15%	+$75.2K	0.01%	606
2016 Q2	$413	Buy	31,941 +7,334	+30%	+$107K	﹤0.01%	732
2016 Q1	$393K	Buy	24,607 +8,144	+49%	+$155K	﹤0.01%	767
2015 Q4	$471K	Buy	16,463 +6,521	+66%	+$181K	﹤0.01%	891
2015 Q3	$283K	Buy	9,942 +263	+3%	+$9.68K	﹤0.01%	974
2015 Q2	$348K	Buy	9,679 +2,405	+33%	+$74.9K	﹤0.01%	1052
2015 Q1	$211K	Buy	+7,274	New	+$192K	﹤0.01%	1080

Other funds holding INSY

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FHAM

Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCP

Fine Capital Partners New York $563M AUM 7.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Commerzbank Aktiengesellschaft's INSY Position: Q1 2017 in Review

Commerzbank Aktiengesellschaft sold out of Insys Therapeutics, Inc. (INSY) in Q1 2017, closing a stake of 33,589 shares — an estimated $309K sold.

Commerzbank Aktiengesellschaft first reported a position in INSY in Q1 2015 and held it in 8 quarters. The position peaked at $471K in Q4 2015. 116 funds tracked by Wall St. Rank hold INSY as of Q1 2017.

Commerzbank Aktiengesellschaft reported no remaining Insys Therapeutics, Inc. position as of Q1 2017 after selling out during the quarter.
Commerzbank Aktiengesellschaft sold 33,589 Insys Therapeutics, Inc. shares in Q1 2017, an estimated $309K.
Commerzbank Aktiengesellschaft first reported a position in Insys Therapeutics, Inc. in Q1 2015 and held it in 8 quarters.
Commerzbank Aktiengesellschaft's Insys Therapeutics, Inc. position peaked at $471K in Q4 2015.
116 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2017.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2017, filed 1 May 2017.